# Biomarkers for Outcomes In Late-life Depression (BOLD)

> **NCT01082237** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 80 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT01082237
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082237, "Biomarkers for Outcomes In Late-life Depression (BOLD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01082237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*